DISEASE-MODIFYING ANTI-Dmard Shared Care Agreement • April 19th, 2021
Document Type: Guideline Version: 3.3 Date of Issue: March 2019 Review Date: March 2022 Lead Director: Medical Director Post Responsible for Update: Consultant Rheumatologist Ratifying Committee: APG Ratified by them in the minutes of: March 2021 Distribution to: All Trust staff via the Trust Intranet
DISEASE-MODIFYING ANTI-Dmard Shared Care Agreement • August 2nd, 2023
Document Type: Guideline Version: 3.4.2 Date of Issue: June 2021 Review Date: August 2022Extended to March 2024 by JMMG 09.2022 Lead Director: Medical Director Post Responsible for Update: Consultant Rheumatologist Ratifying Committee: APG Ratified by them in the minutes of: March 2021 Distribution to: All Trust staff via the Trust Intranet
